Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens - PubMed (original) (raw)
Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens
D A Shafritz et al. N Engl J Med. 1981.
Abstract
We used recombinant-DNA technology and gel electrophoresis to find hepatitis B virus DNA (HBV-DNA) in liver and tumor tissue from patients with hepatocellular carcinoma and chronic liver disease, and to study the integration of HBV-DNA into the genome of these tissues' cells. In 12 patients with hepatocellular carcinoma who had hepatitis B surface antigen (HBsAg) in their serum, integrated HBV-DNA was identified in the tumors; it was also found in tumors from three of eight patients who were seronegative for HBsAg but positive for antibody to HBsAg. In some cases, integrated HBV-DNA was also present in nontumorous liver tissue that had the same hybridization pattern or one different from that of the tumor. In five carriers of HBsAg who had evidence of the carrier state and chronic liver disease for less than two years, HBV-DNA was present but not integrated in liver tissue. In the two patients who had carried HBsAg for more than eight years, HBV-DNA was integrated into the host genome. These data suggest that integration of HBV-DNA into hepatocytes occurs during the course of persistent HBV infection and precedes development of gross neoplasm.
Similar articles
- Integration of HBV-DNA into liver and hepatocellular carcinoma cells during persistent HBV infection.
Shafritz DA. Shafritz DA. J Cell Biochem. 1982;20(3):303-16. doi: 10.1002/jcb.240200310. J Cell Biochem. 1982. PMID: 6302121 - Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen.
Bréchot C, Degos F, Lugassy C, Thiers V, Zafrani S, Franco D, Bismuth H, Trépo C, Benhamou JP, Wands J, et al. Bréchot C, et al. N Engl J Med. 1985 Jan 31;312(5):270-6. doi: 10.1056/NEJM198501313120503. N Engl J Med. 1985. PMID: 2981408 - HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S, Nakashima Y, Kojiro M, Tabor E. Momosaki S, et al. J Viral Hepat. 2005 May;12(3):325-9. doi: 10.1111/j.1365-2893.2005.00586.x. J Viral Hepat. 2005. PMID: 15850475 - [Hepatocellular carcinoma, hepatitis B virus and the immune system].
Grob PJ. Grob PJ. Schweiz Med Wochenschr. 1986 Aug 23;116(34):1133-45. Schweiz Med Wochenschr. 1986. PMID: 3020684 Review. German. - [HBV and hepatocellular carcinoma].
Kaneko S, Murakami S, Kobayashi K, Hattori N. Kaneko S, et al. Gan To Kagaku Ryoho. 1987 Mar;14(3 Pt 1):553-60. Gan To Kagaku Ryoho. 1987. PMID: 3030195 Review. Japanese.
Cited by
- The new advance of exosome-based liquid biopsy for cancer diagnosis.
Tang H, Yu D, Zhang J, Wang M, Fu M, Qian Y, Zhang X, Ji R, Gu J, Zhang X. Tang H, et al. J Nanobiotechnology. 2024 Oct 8;22(1):610. doi: 10.1186/s12951-024-02863-0. J Nanobiotechnology. 2024. PMID: 39380060 Free PMC article. Review. - The impact of integrated hepatitis B virus DNA on oncogenesis and antiviral therapy.
Zhang M, Chen H, Liu H, Tang H. Zhang M, et al. Biomark Res. 2024 Aug 15;12(1):84. doi: 10.1186/s40364-024-00611-y. Biomark Res. 2024. PMID: 39148134 Free PMC article. Review. - The Initial Hepatitis B Virus-Hepatocyte Genomic Integrations and Their Role in Hepatocellular Oncogenesis.
Michalak TI. Michalak TI. Int J Mol Sci. 2023 Oct 3;24(19):14849. doi: 10.3390/ijms241914849. Int J Mol Sci. 2023. PMID: 37834296 Free PMC article. Review. - TRIM26 positively affects hepatitis B virus replication by inhibiting proteasome-dependent degradation of viral core protein.
Nakaya Y, Nishizawa T, Nishitsuji H, Morita H, Yamagata T, Onomura D, Murata K. Nakaya Y, et al. Sci Rep. 2023 Aug 21;13(1):13584. doi: 10.1038/s41598-023-40688-3. Sci Rep. 2023. PMID: 37604854 Free PMC article. - The coordinated management of ribosome and translation during injury and regeneration.
Nguyen T, Mills JC, Cho CJ. Nguyen T, et al. Front Cell Dev Biol. 2023 Jun 22;11:1186638. doi: 10.3389/fcell.2023.1186638. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37427381 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical